Reselute, Inc.
Durham, NC
- UEI
- JBMRHJGSMFD6
- CAGE
- 91CW5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 108 Copley Mountain Dr, Durham, NC 27705, USA
- Website
- reselutemedical.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Local and sustained release of antibiotics in the surgical treatment of diabetic charcot foot - charcot osteoarthropathy… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $314,362 | |
| Sttr phase II: development of a antibiotic releasing intramedullary nail for treatment of fracture related infections… | National Science Foundation | $998,921 | |
| Sbir phase i: localized and sustained antibiotic delivery for treatment of periprosthetic joint infection (PJI) in… | National Science Foundation | $295,247 |
About Reselute, Inc.
Reselute, Inc. is a Durham, North Carolina-based corporate entity registered in SAM.gov that specializes in developing advanced orthopedic medical technologies with a focus on innovative implantable devices designed to address complex medical challenges. The company is a self-certified small disadvantaged business and woman-owned small business that has demonstrated expertise in developing medical devices with integrated technological solutions for orthopedic and infectious disease treatment challenges. Reselute's core competency appears to be designing sophisticated medical implants that incorporate advanced antibiotic delivery mechanisms to prevent and treat orthopedic infections, particularly in challenging patient populations such as diabetic patients and those requiring complex fracture interventions.
Reselute, Inc. has secured multiple federal grants from the National Science Foundation and the National Institute of Arthritis and Musculoskeletal and Skin Diseases to advance its medical device innovations. The company's grant-funded projects have focused on developing 3D-printed orthopedic implants with localized antibiotic release capabilities, including a hindfoot intramedullary nail for diabetic Charcot osteoarthropathy patients, an intramedullary nail for treating long bone fracture-related infections, and an orthopedic spacer for periprosthetic joint infection treatment. These projects collectively represent approximately $1.6 million in federal grant funding and aim to create medical technologies that can potentially reduce infection risks, improve patient recovery times, and minimize the need for additional surgical interventions. The grants span different funding mechanisms including Project Grants, Cooperative Agreements, and SBIR/STTR Phase I and Phase II awards, indicating the company's ability to secure competitive federal research and development funding across multiple program categories.
Quick answers
What is Reselute, Inc.'s UEI?
Reselute, Inc.'s Unique Entity ID (UEI) in SAM.gov is JBMRHJGSMFD6.
What is Reselute, Inc.'s CAGE code?
Reselute, Inc.'s CAGE code is 91CW5.
What is Reselute, Inc.'s primary NAICS code?
Reselute, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Reselute, Inc. located?
Reselute, Inc.'s physical address in SAM.gov is 108 Copley Mountain Dr, Durham, NC 27705, USA.
Is Reselute, Inc. registered in SAM.gov?
Yes. Reselute, Inc.'s SAM.gov registration is active through January 15, 2027.
What is Reselute, Inc.'s most recent federal award?
Reselute, Inc.'s most recent federal grant award is Local and sustained release of antibiotics in the surgical treatment of diabetic charcot foot - charcot osteoarthropathy… (R44AR086730), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on September 7, 2025.
On GovTribe
See Reselute, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors